IL-13 contributes to the start of AD and itching and, acting with IL-4, lead to the aggravation of EBD by downregulating involucrin and FLG, via inactivation of OVOL1 and stimulation of periostin and IL-24 (Figure 1) (17). This evidence concerns the gene OVOL1 and Alzheimer disease.